BTIG Maintains Buy on Verastem, Lowers Price Target to $18

Verastem, Inc.

Verastem, Inc.

VSTM

0.00

BTIG analyst Jeet Mukherjee maintains Verastem (NASDAQ: VSTM) with a Buy and lowers the price target from $19 to $18.